- Telehealth Visits
- Insurance plan information
Courtney Lane-Donovan, MD, PhD
Neurology- Telehealth Visits
- Insurance plan information
Courtney Lane-Donovan, MD, PhD
Neurology- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Neurology, American Board of Psychiatry and Neurology
Fellowship
- Behavioral Neurology, UCSF Graduate Medical Education
Residency
- Neurology, UCSF Graduate Medical Education
Internship
- Neurology, UCSF Graduate Medical Education
Degree
- MD, UT Southwestern Medical Center (Allied Health)
My expertise
Specialties
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%222896%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%222896%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Showing 1-6 of 8 reviews
- January 6, 20265 out of 5 Stars
I would highly recommend Dr. Lane-Donovan
- July 23, 20255 out of 5 Stars
Very informative and helpful in answering questions, as well as arranging follow-up appointments and care. I am very pleased with her as my provider.
- March 17, 20255 out of 5 Stars
Very good advice for my FTD
- July 8, 20245 out of 5 Stars
I would rate all of the above "Excellent.
- June 24, 20245 out of 5 Stars
Dr. Lane-Donavan is exceptional in her understanding and ability to communicate clearly at an appropriate level. I especially appreciate that she has a PhD and speaks the same language as I (I too have a PhD and a research background.
- May 22, 20241.3 out of 5 Stars
I've only had excellent care from any of your providers before, but Dr. Lane Donovan was rude and not at all helpful.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.